Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure

Novartis Pharmaceuticals · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
chronic-heart-failureheart-failureimmunogenicity
chronic heart failure, chronic heart failure, chf, heart failure, hf, immunogenicity, anti-bodies, hypersensitivity, serelaxin, relax-repeat, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 994887
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.